Table 4 Patient-supported costs and state-supported costs over 10 years
From: Economic efficiency of primary care for CVD prevention and treatment in Eastern European countries
Scenario | Total costs | Patient-supported | State-supported | Patient’s income | Percent allocated for health |
|---|---|---|---|---|---|
A1 | 131303.61 | 100535.07 | 30768.54 | 119255.50 | 84.30% |
A2 | 219787.56 | 100535.07 | 119252.49 | 77423.45 | 129.85% |
A (average) | 175545.59 | 100535.07 | 75010.52 | 98339.48 | 102.23% |
B1 | 33205.63 | 14213.02 | 18992.61 | 119255.50 | 11.92% |
B2 | 118091.04 | 87586.77 | 30504.27 | 119255.50 | 73.44% |
B3 | 193302.39 | 87586.77 | 105715.62 | 75106.09 | 116.62% |
B (average) | 114866.35 | 63128.85 | 52070.83 | 104539.03 | 60.39% |
Average costs | 139138.05 | 78091.34 | 61246.71 | 102059.21 | 76.52% |